과제정보
This work was supported by the Research Resettlement Fund for the new faculty of Seoul National University, Creative-Pioneering Researchers Program through Seoul National University, grants from Seoul National University College of Medicine, National Research Foundation of Korea (NRF) grant funded by the Korean government (MSIT) (No. NRF2021R1C1C1013220 and No. NRF2022R1A5A102641311) and BK21 Four Biomedical Science Program.
참고문헌
- Yu JR, Lee CH, Oksuz O, Stafford JM and Reinberg D (2019) PRC2 is high maintenance. Genes Dev 33, 903-905 https://doi.org/10.1101/gad.325050.119
- Margueron R and Reinberg D (2011) The polycomb complex PRC2 and its mark in life. Nature 469, 343-349 https://doi.org/10.1038/nature09784
- Chen S, Jiao L, Shubbar M, Yang X and Liu X (2018) Unique structural platforms of Suz12 dictate distinct classes of PRC2 for chromatin binding. Mol Cell 69, 802-819 https://doi.org/10.1016/j.molcel.2018.01.018
- Margueron R, Justin N, Ohno K et al (2009) Role of the polycomb protein EED in the propagation of repressive histone marks. Nature 461, 762-767 https://doi.org/10.1038/nature08398
- Cao R, Wang L, Wang H et al (2002) Role of histone H3 lysine 27 methylation in polycomb-group silencing. Science 298, 1039-1043 https://doi.org/10.1126/science.1076997
- Czermin B, Melfi R, McCabe D, Seitz V, Imhof A and Pirrotta V (2002) Drosophila enhancer of Zeste/ESC complexes have a histone H3 methyltransferase activity that marks chromosomal Polycomb sites. Cell 111, 185-196 https://doi.org/10.1016/S0092-8674(02)00975-3
- Kuzmichev A, Nishioka K, Erdjument-Bromage H, Tempst P and Reinberg D (2002) Histone methyltransferase activity associated with a human multiprotein complex containing the enhancer of zeste protein. Genes Dev 16, 2893-2905 https://doi.org/10.1101/gad.1035902
- Justin N, Zhang Y, Tarricone C et al (2016) Structural basis of oncogenic histone H3K27M inhibition of human polycomb repressive complex 2. Nat Commun 7, 11316
- Lee CH, Yu JR, Kumar S et al (2018) Allosteric activation dictates PRC2 activity independent of its recruitment to chromatin. Mol Cell 70, 422-434 https://doi.org/10.1016/j.molcel.2018.03.020
- Hansen KH, Bracken AP, Pasini D et al (2008) A model for transmission of the H3K27me3 epigenetic mark. Nat Cell Biol 10, 1291-1300
- Oksuz O, Narendra V, Lee CH et al(2018) Capturing the onset of PRC2-mediated repressive domain formation. Mol Cell 70, 1149-1162 https://doi.org/10.1016/j.molcel.2018.05.023
- Cao R and Zhang Y (2004) SUZ12 is required for both the histone methyltransferase activity and the silencing function of the EED-EZH2 complex. Mol Cell 15, 57-67 https://doi.org/10.1016/j.molcel.2004.06.020
- Schmitges FW, Prusty AB, Faty M et al (2011) Histone methylation by PRC2 is inhibited by active chromatin marks. Mol Cell 42, 330-341 https://doi.org/10.1016/j.molcel.2011.03.025
- Chammas P, Mocavini I and Di Croce L (2020) Engaging chromatin: PRC2 structure meets function. Br J Cancer 122, 315-328
- Glancy E, Ciferri C and Bracken AP (2021) Structural basis for PRC2 engagement with chromatin. Curr Opin Struct Biol 67, 135-144 https://doi.org/10.1016/j.sbi.2020.10.017
- Piunti A, Smith ER, Morgan MAJ et al (2019) Catacomb: an endogenous inducible gene that antagonizes H3K27 methylation activity of polycomb repressive complex 2 via an H3K27M-like mechanism. Sci Adv 5, eaax2887
- Ragazzini R, Perez-Palacios R, Baymaz IH et al (2019) EZHIP constrains polycomb repressive complex 2 activity in germ cells. Nat Commun 10, 3858
- Conway E, Jerman E, Healy E et al (2018) A family of vertebrate-specific polycombs encoded by the LCOR/LCORL genes balance PRC2 subtype activities. Mol Cell 70, 408-421 https://doi.org/10.1016/j.molcel.2018.03.005
- Liefke R, Karwacki-Neisius V, Shi Y et al (2016) EPOP interacts with elongin BC and USP7 to modulate the chromatin landscape. Mol Cell 64, 659-672 https://doi.org/10.1016/j.molcel.2016.10.019
- Beringer M, Pisano P, Di Carlo V et al (2016) EPOP functionally links elongin and polycomb in pluripotent stem cells. Mol Cell 64, 645-658 https://doi.org/10.1016/j.molcel.2016.10.018
- Hojfeldt JW, Hedehus L, Laugesen A, Tatar T, Wiehle L and Helin K (2019) Non-core subunits of the PRC2 complex are collectively required for its target-site specificity. Mol Cell 76, 423-436 https://doi.org/10.1016/j.molcel.2019.07.031
- Laugesen A, Hojfeldt JW and Helin K (2019) Molecular mechanisms directing PRC2 recruitment and H3K27 methylation. Mol Cell 74, 8-18 https://doi.org/10.1016/j.molcel.2019.03.011
- Lee CH, Holder M, Grau D et al (2018) Distinct stimulatory mechanisms regulate the catalytic activity of polycomb repressive complex 2. Mol Cell 70, 435-448 https://doi.org/10.1016/j.molcel.2018.03.019
- Son J, Shen SS, Margueron R and Reinberg D (2013) Nucleosome-binding activities within JARID2 and EZH1 regulate the function of PRC2 on chromatin. Genes Dev 27, 2663-2677 https://doi.org/10.1101/gad.225888.113
- Margueron R, Li G, Sarma K et al (2008) Ezh1 and Ezh2 maintain repressive chromatin through different mechanisms. Mol Cell 32, 503-518 https://doi.org/10.1016/j.molcel.2008.11.004
- Grau D, Zhang Y, Lee CH et al (2021) Structures of monomeric and dimeric PRC2:EZH1 reveal flexible modules involved in chromatin compaction. Nat Commun 12, 714
- Yuan W, Wu T, Fu H et al (2012) Dense chromatin activates polycomb repressive complex 2 to regulate H3 lysine 27 methylation. Science 337, 971-975 https://doi.org/10.1126/science.1225237
- Bratkowski M, Yang X and Liu X (2018) An evolutionarily conserved structural platform for PRC2 inhibition by a class of Ezh2 inhibitors. Sci Rep 8, 9092
- Bracken AP, Pasini D, Capra M, Prosperini E, Colli E and Helin K (2003) EZH2 is downstream of the pRB-E2F pathway, essential for proliferation and amplified in cancer. EMBO J 22, 5323-5335 https://doi.org/10.1093/emboj/cdg542
- Von Schimmelmann M, Feinberg PA, Sullivan JM et al (2016) Polycomb repressive complex 2 (PRC2) silences genes responsible for neurodegeneration HHS public access. Nat Neurosci 19, 1321-1330 https://doi.org/10.1038/nn.4360
- Shen X, Liu Y, Hsu YJ et al (2008) EZH1 mediates methylation on histone H3 lysine 27 and complements EZH2 in maintaining stem cell identity and executing pluripotency. Mol Cell 32, 491-502 https://doi.org/10.1016/j.molcel.2008.10.016
- Lavarone E, Barbieri CM and Pasini D (2019) Dissecting the role of H3K27 acetylation and methylation in PRC2 mediated control of cellular identity. Nat Commun 10, 1-16 https://doi.org/10.1038/s41467-018-07882-8
- Jadhav U, Manieri E, Nalapareddy K et al (2020) Replicational dilution of H3K27me3 in mammalian cells and the role of poised promoters. Mol Cell 78, 141-151 https://doi.org/10.1016/j.molcel.2020.01.017
- He A, Ma Q, Cao J et al (2012) Polycomb repressive complex 2 regulates normal development of the mouse heart. Circ Res 110, 406-415 https://doi.org/10.1161/CIRCRESAHA.111.252205
- Ezhkova E, Pasolli HA, Parker JS et al (2009) Ezh2 orchestrates gene expression for the stepwise differentiation of tissue-specific stem cells. Cell 136, 1122-1135 https://doi.org/10.1016/j.cell.2008.12.043
- Ezhkova E, Lien W-H, Stokes N, Pasolli HA, Silva JM and Fuchs E (2011) EZH1 and EZH2 cogovern histone H3K27 trimethylation and are essential for hair follicle homeostasis and wound repair. Genes Dev 25, 485-498 https://doi.org/10.1101/gad.2019811
- Hidalgo I, Herrera-Merchan A, Ligos JM et al (2012) Ezh1 is required for hematopoietic stem cell maintenance and prevents senescence-like cell cycle arrest. Cell Stem Cell 11, 649-662
- von Schimmelmann M, Feinberg PA, Sullivan JM et al (2016) Polycomb repressive complex 2 (PRC2) silences genes responsible for neurodegeneration. Nat Neurosci 2, 1-14 https://doi.org/10.1038/4502
- Vo LT, Kinney MA, Liu X et al (2018) Regulation of embryonic haematopoietic multipotency by EZH1. Nature 553, 506-510 https://doi.org/10.1038/nature25435
- Ai S, Yu X, Li Y et al (2017) Divergent requirements for EZH1 in heart development versus regeneration. Circ Res 121, 106-112 https://doi.org/10.2307/25564847
- Hoy SM (2020) Tazemetostat: first approval. Drugs 80, 513-521 https://doi.org/10.1007/s40265-020-01288-x
- Chen Z, Yang P, Li W et al (2018) Expression of EZH2 is associated with poor outcome in colorectal cancer. Oncol Lett 15, 2953-2961
- Huet S, Xerri L, Tesson B et al (2017) EZH2 alterations in follicular lymphoma: biological and clinical correlations. Blood Cancer J 7, e555
- Varambally S, Dhanasekaran SM, Zhou M et al (2002) The polycomb group protein EZH2 is involved in progression of prostate cancer. Nature 419, 624-629 https://doi.org/10.1038/nature01075
- Zingg D, Debbache J, Schaefer SM et al (2015) The epigenetic modifier EZH2 controls melanoma growth and metastasis through silencing of distinct tumour suppressors. Nat Commun 6, 6051
- Takata K, Miyata-Takata T, Sato Y and Yoshino T (2014) Pathology of follicular lymphoma. J Clin Exp Hematop 54, 3-9 https://doi.org/10.3960/jslrt.54.3
- Bodor C, Grossmann V, Popov N et al (2013) EZH2 mutations are frequent and represent an early event in follicular lymphoma. Blood 122, 3165-3168
- Yap DB, Chu J, Berg T et al (2011) Somatic mutations at EZH2 Y641 act dominantly through a mechanism of selectively altered PRC2 catalytic activity, to increase H3K27 trimethylation. Blood 117, 2451-2459 https://doi.org/10.1182/blood-2010-11-321208
- McCabe MT, Graves AP, Ganji G et al (2012) Mutation of A677 in histone methyltransferase EZH2 in human B-cell lymphoma promotes hypertrimethylation of histone H3 on lysine 27 (H3K27). Proc Natl Acad Sci 109, 2989-2994 https://doi.org/10.1073/pnas.1116418109
- Ott HM, Graves AP, Pappalardi MB et al (2014) A687V EZH2 is a driver of histone H3 lysine 27 (H3K27) hypertrimethylation. Mol Cancer Ther 13, 3062-3073 https://doi.org/10.1158/1535-7163.MCT-13-0876
- Souroullas GP, Jeck WR, Parker JS et al (2016) An oncogenic Ezh2 mutation induces tumors through global redistribution of histone 3 lysine 27 trimethylation. Nat Med 22, 632-640
- Becker PB and Workman JL (2013) Nucleosome remodeling and epigenetics. Cold Spring Harb Perspect Biol 5, a017905
- Euskirchen G, Auerbach RK and Snyder M (2012) SWI/SNF chromatin-remodeling factors: multiscale analyses and diverse functions. J Biol Chem 287, 30897-30905 https://doi.org/10.1074/jbc.R111.309302
- Kadoch C, Williams RT Calarco JP et al (2017) Dynamics of BAF-Polycomb complex opposition on heterochromatin in normal and oncogenic states. Nat Genet 49, 213-222 https://doi.org/10.1038/ng.3734
- Zhang W, Chronis C, Chen X et al (2019) The BAF and PRC2 complex subunits dpf2 and eed antagonistically converge on Tbx3 to control ESC differentiation. Cell Stem Cell 24, 138-152
- Schuettengruber B, Bourbon HM, Di Croce L and Cavalli G (2017) Genome regulation by polycomb and trithorax: 70 years and counting. Cell 171, 34-57 https://doi.org/10.1016/j.cell.2017.08.002
- Wilson BG, Wang X, Shen X et al (2010) Epigenetic antagonism between polycomb and SWI/SNF complexes during oncogenic transformation. Cancer Cell 18, 316-328 https://doi.org/10.1016/j.ccr.2010.09.006
- Mittal P, and Roberts CWM (2020) The SWI/SNF complex in cancer - biology, biomarkers and therapy. Nat Rev Clin Oncol 17, 435-448 https://doi.org/10.1038/s41571-020-0357-3
- Weber CM, Hafner A, Kirkland JG et al (2021) mSWI/SNF promotes polycomb repression both directly and through genome-wide redistribution. Nat Struct Mol Biol 28, 501-511 https://doi.org/10.1038/s41594-021-00604-7
- Calebiro D, Grassi ES, Eszlinger M et al (2016) Recurrent EZH1 mutations are a second hit in autonomous thyroid adenomas. J Clin Invest 126, 3383-3388 https://doi.org/10.1172/JCI84894
- Song YS and Park YJ (2019) Genomic characterization of differentiated thyroid carcinoma. Endocrinol Metab 34, 1-10 https://doi.org/10.3803/enm.2019.34.1.1
- Jung CK, Kim Y, Jeon S, Jo K, Lee S and Bae JS (2018) Clinical utility of EZH1 mutations in the diagnosis of follicular-patterned thyroid tumors. Hum Pathol 81, 9-17 https://doi.org/10.1016/j.humpath.2018.04.018
- Poepsel S, Kasinath V and Nogales E (2018) Cryo-EM structures of PRC2 simultaneously engaged with two functionally distinct nucleosomes. Nat Struct Mol 25, 154-162 https://doi.org/10.1038/s41594-018-0023-y